pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

Agendas for pharmaceutical care service R&D in Korea

AreasCodeAgendas
Institutional pharmaceutical care service R&DH1Development and standardization of pharmaceutical care service for infectious disease patients
H2Development and standardization of pharmaceutical care service for geriatric disease patients
H3Development and standardization of pharmaceutical care service for metabolic/chronic disease patients
H4Development and standardization of pharmaceutical care service for pediatric or undeserved population
H5Development and standardization of pharmaceutical care service for surgical patients
H6Development and standardization of CPR pharmaceutical team care service
H7Development and standardization of pharmaceutical care service for cardiovascular/circulatory disorder patients
H8Development and standardization of pharmaceutical care service for cancer patients
H9Development and standardization of pharmaceutical care service for emergency patients
H10Development and standardization of pharmaceutical care service for psychiatric disorder patients
H11Development and standardization of pharmaceutical care service for critically ill patients
H12Development and standardization of palliative pharmaceutical care service for hospice or terminal patients
H13Development and standardization of pharmaceutical care service for respiratory disease patients

Community pharmaceutical care service R&DC1Development of MTM service in community pharmacy
C2Development and implementation of smart GPP in community pharmacy
C3Development and implementation of pharmacy-based immunizations services
C4Development and implementation of postal service for prescription medications in community pharmacy
C5Development of remote prescription dispensing services and standardization of pharmaceutical records through establishing an electronic prescription network of community pharmacies
C6Development of pharmacy service for the specialty drugs
C7Development of public service for the prevention of drug abuse and addiction, and safety measures for high risk drugs
C8Development of counseling service for health management in community pharmacy

Public-health related pharmaceutical care service R&DP1Development of home pharmaceutical care services for medical care and elderly nursing facility residents
P2Development of addiction management service for drug addiction
P3Development of asthma self-medication management program for vulnerable adolescent patients
P4Development of a Korean health literacy of medicine assessment tool for improving medication adherence

CPR, cardiopulmonary resuscitation; GPP, good pharmacy practice; MTM, medication therapy management; R&D, research and development

Korean J Clin Pharm 2019;29:45-55 https://doi.org/10.24304/kjcp.2019.29.1.45
© 2019 Korean J Clin Pharm